← All trials
NCT00435955
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2000
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Azienda Ospedaliera San Giovanni BattistaLead sponsor
- University of MilanOverall official - principal investigator
- Gruppo Italiano Trapianto di Midollo OsseoCollaborator
- Gruppo Italiano Studio LinfomiCollaborator
- RocheCollaborator
- University of TurinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.